Skip to content

AIDX

20/20 Biolabs, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.47
−1.36%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-20.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Apr 6, 2026Bergman Alan B. · officer: Chief Financial OfficerA-Award100,000$1.88
Apr 6, 2026Zhou Jiming · officer: Chief Operating OfficerA-Award150,000$1.88
Mar 4, 2026Cohen Jonathan M · director, 10 percent owner, officer: Chief Executive OfficerA-Award352,936$3.39
Institutional positioning

13F filings over the trailing two quarters

New 17Increased 2Reduced 3Sold out 2
FilerActionSharesFiled
CRESSET ASSET MANAGEMENT, LLCNew Position264,368May 15, 2026
Cresset Asset Management, LLCReduced240,122Aug 14, 2026
HRT FINANCIAL LPNew Position89,273Aug 14, 2026
VANGUARD FIDUCIARY TRUST CONew Position52,087Aug 13, 2026
GEODE CAPITAL MANAGEMENT, LLCNew Position49,141Aug 12, 2026
Atlantic Union Bankshares CorpNew Position35,099Aug 11, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position24,530Aug 13, 2026
CITADEL ADVISORS LLCIncreased23,205Sep 2, 2026
CITADEL ADVISORS LLCNew Position16,227May 15, 2026
BANK OF AMERICA CORP /DE/New Position13,024Aug 14, 2026
XTX TOPCO LTDNew Position10,329May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPNew Position10,014Aug 14, 2026
UBS GROUP AGNew Position8,314May 5, 2026
MCDONALD PARTNERS LLCNew Position2,800Jul 28, 2026
MAI CAPITAL MANAGEMENTNew Position1,000May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 6, 2026